CD8+ cytotoxic T lymphocytes (CTLs), activated by MHC class I-presented epitopes, target tumor cells by releasing perforin and granzymes or inducing apoptosis through Fas ligand interactions [60]. This evidence concerns the gene CD8A and neoplasm.